Prohibits insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription which was initially written for seven days or less.
STATE OF NEW YORK
________________________________________________________________________
6139
2019-2020 Regular Sessions
IN ASSEMBLY
February 28, 2019
___________
Introduced by M. of A. DeSTEFANO -- read once and referred to the
Committee on Insurance
AN ACT to amend the insurance law, in relation to prohibiting insurance
companies from imposing a co-pay pursuant to a follow up visit with a
physician in order to receive a refill on an opioid drug prescription
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Subsection (i) of section 3216 of the insurance law is
2 amended by adding a new paragraph 35 to read as follows:
3 (35) Every policy which provides coverage for opioid drug
4 prescriptions shall not impose any fee, co-payment, co-insurance, deduc-
5 tible or other condition on any insured who requires a follow up
6 appointment to receive an additional opioid drug prescription or a
7 refill of an opioid drug prescription after an initial prescription for
8 such opioid drug prescription which was written for a period of seven
9 days or less. Such prohibition on any fee, co-payment, co-insurance,
10 deductible or other condition is limited to one visit or one refill
11 after the initial appointment or prescription. Upon any subsequent
12 consultation for the same pain, the practitioner may issue, in accord-
13 ance with this subsection, any appropriate renewal, refill, or new
14 prescription for the opioid or any other drug.
15 § 2. This act shall take effect on the ninetieth day after it shall
16 have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD02495-01-9
